67.81USD+1.47%Mkt Cap: 8.16B USDP/E: 24.14Last update: 2026-06-01
Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap8.16B USD
Enterprise Value9.75B USD
Revenue (TTM)1.51B USD
Gross Profit1.17B USD
Net Income (TTM)316.89M USD
Revenue/Share12.72 USD
Last Price67.81 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees423
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS40637H1095
Valuation
P/E (Trailing)24.14
P/E (Forward)6.73
PEG—
EV/EBITDA10.23
EV/Revenue6.46
P/S5.23
P/B35.91
EPS (TTM)2.85
EPS (Forward)9.89
52W Range
51.0654% of range82.22
52W High82.22 USD
52W Low51.06 USD
Profitability
Gross Margin83.62%
Oper. Margin48.98%
EBITDA Margin63.18%
Profit Margin22.69%
ROE649.18%
ROA12.55%
Growth
Revenue Growth42.20%
Earnings Growth31.20%
Cash Flow & Leverage
Operating CF651.56M USD
CapEx (TTM)294.74M USD
FCF Margin15.12%
FCF Yield2.80%
Net Debt1.86B USD
Net Debt/EBITDA1.95
Balance Sheet
Debt/Equity43.89
Current Ratio2.76
Quick Ratio2.14
Book Value/Sh1.853 USD
Cash/Share2.686 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.2 (Buy)
Target (Mean)83.90 USD
Target Range57.00 USD – 96.00 USD
# Analysts10
Ownership
Shares Out.118.61M
Float117.28M
Insiders1.06%
Institutions107.63%
Short Interest
Short Ratio7.9d
Short % Float14.60%
Short % Out.11.29%
Shares Short13.39M
Short (prev mo.)14.26M
Technical
SMA 5066.00 (+2.7%)
SMA 20069.21 (-2.0%)
Beta0.88
S&P 52W Chg27.94%
Avg Vol (30d)1.59M
Avg Vol (10d)1.76M
Technical Indicators
RSI (14)47.6
MACD0.5788
MACD Signal0.6201
MACD Hist.-0.0414
BB Upper71.47 USD
BB Middle67.46 USD
BB Lower63.46 USD
BB Width11.88%
ATR (14)2.196 USD
Vol Ratio (20d)0.48x